SBC Medical Group Holdings Incorporated

NASDAQ:SBC

Consulting Services

Industrials
$6.27 +1.17%

+$0.04 today

Market cap
$644.85M
Beta
0.59
P/E (TTM)
7.6
EPS (TTM)
$0.40
52W Low $2.78High $5.75

Volume 0.56M

Average 0.12M

SBC Research & Development

Spending on developing new products, technologies, and improvements to existing offerings.

SBC Medical Group Holdings IncorporatedNASDAQ: SBC

Research & Development · Q1 FY2026 · quarter ended Mar 2026

Research & development remains negative

Q1 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.

Context

  • Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
  • Research & development increased in 0 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$0— QoQ
Last fiscal yearDec 2025
$0— YoY
LTMMar 2026
$0— YoY
Research & Development past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Research & Development history

USD · from the income statement

Latest · FY2025
0 USD
Year-over-year change
—

Research & Development vs competitors

How SBC compares with its peers on the latest reported figures

  • SBC's LTM Mar 2026 research & development of $0 is the 2nd highest of the 3 companies compared; the peer median is $26.27M.
  • Research & development amounts to 0.0% of revenue for SBC, versus a peer median of 8.4%.
SBC Competitors Peer median
Research & Development for SBC and competitors
Company Period LTM YoY 3-year CAGR% of revenue
HSTMHealthStream, Inc.LTM Mar 2026$52.54M +7.4%+4.8%16.9%
SBCSBC Medical Group Holdings IncorporatedLTM Mar 2026$0 ——0.0%
RYOJrYojbaba Co., Ltd. Common SharesFY2024$0 ——0.0%
Peer median (excluding SBC) $26.27M+7.4%+4.8%8.4%

Competitors are the stored peer set for SBC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue174.16M193.54M205.42M173.61M
Cost of Revenue59.33M56.24M49.37M46.32M
Gross Profit114.83M137.3M156.05M127.28M
Gross Margin65.9%70.9%76.0%73.3%
Research & Development0000
Selling, General & Admin93.48M66.23M70.09M59.8M
Operating Expenses94.72M66.64M85.75M59.8M
Depreciation & Amortization5.93M12.25M3.8M2.68M
EBITDA29.64M85.87M77.28M84.91M
EBITDA Margin17.0%44.4%37.6%48.9%
Operating Income20.12M70.66M70.3M67.49M
Operating Margin11.6%36.5%34.2%38.9%
Interest Income472.38K86.75K19.94K198.32K
Interest Expense31.44K45.29K28.3K160.58K
Other Income / Expenses3.56M2.92M3.15M14.58M
Income Before Tax23.68M73.58M73.46M82.07M
Pre-Tax Margin13.6%38.0%35.8%47.3%
Income Tax Expense18.12M35.02M26.77M31.02M
Net Income6.32M39.37M46.61M50.99M
Net Margin3.6%20.3%22.7%29.4%
EPS (Basic)0.060.420.480.50
EPS (Diluted)0.060.420.480.50
Weighted Avg Shares15.07M94.19M96.56M103M
Weighted Avg Shares (Diluted)15.07M94.19M96.56M103M

SBC Medical Group Holdings Incorporated

NASDAQ:SBC

Intrinsic Alpha fair value

Locked

Current Price

$6.27

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.